The stability of YKL-40, a mammalian member of the family of 18 glycosylhydrolases, in blood samples handled under different temperatures and different time intervals before centrifugation was studied in paired serum and plasma samples from 25 healthy premenopausal Danish women. Signi®cant elevations of YKL-40 were found in 8 paired serum samples left on the clot for more than 3 h at room temperature compared to paired serum samples left on the clot for 3 h or less. Signi®cant elevations of YKL-40 were found in 8 paired plasma (EDTA) samples left on the blood cells for more than 8 h at room temperature compared to paired plasma (EDTA) samples left on the blood cells for 8 h or less. No elevations were found in YKL-40 levels in serum samples left on the clot at 4³C for 24 h or in plasma (EDTA) samples left on the blood cells for 72 h before centrifugation. Signi®cantly lower concentrations of YKL-40 were measured in plasma (EDTA) compared with paired serum samples with a serum/plasma ratio of 1.4 in samples left on the clot or on blood cells at 4³C for up to 24 h. Repetitive freezing and thawing had no signi®cant effect on the measured YKL-40 concentrations. In conclusion, we have shown that YKL-40 is very dependent on the handling procedures. All the blood samples must be processed into plasma (EDTA) within 8 h at room temperature or into serum in less than 3 h at room temperature. If this is not possible, the blood samples must be stored at 4³C until processed.
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INTRODUCTION
YKL-40 is a member of the 18 glycosylhydrolase family [1, 2] , a protein family which includes chitinases and chitinase-related proteins. YKL-40 is a lectin that binds chitin [3] and heparin [4] , but it has no chitinase activity [2, 3] . The protein has been termed YKL-40 from its molecular weight (40 kDa) and the one-letter code for its three N-terminal amino acids [5] and is also named human cartilage glycoprotein-39 [2] . The sequence of the gene has been published, but promotor analysis and regulatory factors have not been described [6] . Although the physiological function of YKL-40 is unknown, the pattern of its expression in the normal and disease state suggests a role in remodelling or degradation of the extracellular matrix. YKL-40 is secreted in large amounts in vitro by the MG63 human osteosarcoma cell line [5] and as a protein expressed by murine mammary tumours initiated by neu/ras oncogenes [7] .
Recently, it has been demonstrated that the serum YKL-40 level is elevated in patients with colorectal cancer and in patients with recurrent metastatic breast cancer compared to the YKL-40 level in healthy controls. In both studies a signi®cant association between increased serum YKL-40 level and short survival was found. Serum YKL-40 may therefore be used as a prognostic biochemical marker of survival [8, 9] . We therefore planned to include YKL-40 measurement in an ovarian cancer study. Because the study involved blood sampling at different hospitals and transport of the blood samples to a central laboratory, we undertook this study to assess the stability of YKL-40 in the 1 ± 3 day time period required for postal delivery.
MATERIALS AND METHODS

Subjects
The study population consisted of 25 healthy premenopausal women from Denmark. The blood samples were collected in three different sets. One set consisted of serum samples from 8 women (set A), another of serum and paired plasma samples (EDTA and heparin) from 9 women (set B), and a third set of serum and plasma (EDTA) samples from 8 women (set C). The collection tubes, the storage temperature before centrifugation and the length of storage before centrifugation were changed between the different groups of samples. All samples were then centrifuged at 20006g for 10 min, and the plasma or serum samples were stored at 220³C until YKL-40 analysis was performed. In addition, to investigate the effect of repetitive thawing and freezing the serum from 9 women (set B) was divided into 8 aliquots and frozen within 1 h from venipuncture. After 24 h, seven aliquots from each woman were thawed at room temperature and refrozen after 1 h. This process was repeated daily, leaving one aliquot frozen each day, until the last aliquot was thawed and refrozen after 7 days before YKL-40 analysis.
Laboratory analysis
Serum and plasma YKL-40 concentrations were determined in duplicates using an ELISA system developed by Harvey et al. [10] in accordance with the manufacturer's instruction (Metra Biosystems, Mountain View, CA, USA). The sensitivity of the assay was 20 mg L 21 and the intra-and interassay variations were 3.6% and 5.3%, respectively (n~67).
Statistical analysis
All distributions were examined for normality before the application of parametric analyses. A paired t-test was used for data examination.
RESULTS
At room temperature a minor decrease in YKL-40 mean level in 8 plasma (EDTA) samples (set C) left on the blood cells for 3 h was seen compared to samples left on the blood cells for 1 h (p~0.05). In contrast, a non-signi®cant increase was found in plasma (EDTA) samples left on the blood cells for 8 h at room temperature before separation compared to samples left for 1 h (p~0.77). For plasma (EDTA) samples left on blood cells at room temperature for 24 and 72 h before plasma pipetted off the blood cells, the increases in the YKL-40 levels were signi®cant compared to samples left on the Table I) .
A small increase in serum YKL-40 concentrations was observed in 8 samples (set A) left on the clot at room temperature for 3 h (p~0.054), but the elevation in serum YKL-40 was highly signi®cant after 72 h (p~0.004) compared with paired serum samples separated by centrifugation followed by pipetting off the clot 1 h after venipuncture (Table II) . No difference was found in serum YKL-40 levels between samples left on the clot at 4³C for 1 h and 3 h (p~0.13) (Table II) . Signi®cant increases were found in serum YKL-40 levels when samples left on the clot at 4³C for 1 h were compared to paired samples left on the clot at 4³C for 72 h (p~0.007) (Table II) . In the third set of samples from 8 healthy women (set C) the serum YKL-40 levels were stable in samples left on the clot at 4³C for 8 h and 24 h compared to samples centrifuged and pipetted off the clot after 1 h (8 h: p~0.32; and 24 h: p~0.15). In the paired samples left on the clot at room temperature, signi®cant increases in serum YKL-40 levels were found after 8 h (p~0.001) and 24 h (p~0.001) compared to samples left on the clot for only 1 h before centrifugation and separation off the serum from the clot by pipetting.
YKL-40 levels were signi®cantly higher in serum compared to paired plasma samples ( , p~0.004) centrifuged after 1 h at room temperature. The lowest YKL-40 levels were found in EDTA plasma compared to the corresponding serum or heparin levels. The serum/plasma ratio of YKL-40 was 1.4 after 1 h, 8 and 24 h at 4³C, but increased in serum and plasma samples that had been left on the clot or left on the blood cells at room temperature for 8 and 24 h (Table III) .
Repetitive freezing and thawing of the serum up to eight times did not signi®cantly affect the serum YKL-40 levels in paired samples (set B) (Table IV) . Number of samples repetitively analysed~8. SD~standard deviation. * The p values are the signi®cance levels between serum at 1 h and the actual samples at 3 h or 72 h.
DISCUSSION
We found levels of YKL-40 to be sensitive to different handling conditions. In serum left on the clot at 4³C the YKL-40 levels were stable for up to 24 h, but after 72 h the serum level was signi®cantly increased. The YKL-40 levels were stable in plasma (EDTA) left on the blood cells for 72 h when stored at 4³C before centrifugation followed by plasma pipetted off the blood cells. The most important ®nding of the present study was seen in blood samples left at room temperature before separation into serum or plasma by centrifugation. We found signi®cant increases in YKL-40 levels in serum (55% increase) and in plasma (EDTA) (25% increase) left for 24 h before separation compared to the levels in serum and plasma samples left on the clot or left on the blood cells for 1 h at room temperature before separation. These ®ndings may seriously in¯uence the speci®city of YKL-40 in clinical studies, where the samples are transported from the sampling place to a central laboratory. Blood samples drawn for the YKL-40 analysis should therefore be processed into serum within 3 h or for EDTA-plasma samples in less than 8 h. If the blood samples have to be transported for a longer time period before centrifugation and separation of serum or plasma, the samples should be stored and shipped at 4³C.
The most likely explanation for the timedependent increase in YKL-40 levels at room temperature is that a degranulation of neutrophils occurs in the blood sample. YKL-40 is present in the speci®c granules of human neutrophils isolated from the blood of healthy subjects [11] and is released from these granules by exocytosis. It is well known that neutrophils degranulate in blood samples during prolonged storage and release the proteins in the granules [12, 13] . The YKL-40 levels were higher in serum compared to plasma (EDTA and heparin) and this is in accordance with other studies that have reported signi®cantly higher levels of lactoferrin and neutrophil gelatinaseassociated lipocalin NGAL (proteins present in the speci®c granules of neutrophils) in serum compared with plasma [13] . The differences between serum and plasma YKL-40 levels have to be considered when reference intervals are established in future studies.
Serum samples were stable on repetitive freezing and thawing up to eight times. This is re-assuring, as in many studies the samples are frozen for later analysis. Commonly, frozen serum samples also may have been thawed and frozen several times for other analyses when Number of samples repetitively analysed~9. SD~standard deviation. * The p values are the signi®cance levels between the serum/plasma ratio 8 and 24 h and the ratio at 1 h. new tumour marker assays appear. Earlier and future YKL-40 studies performed on correctly processed, frozen and thawed samples will still be trustworthy.
